KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Quest Diagnostics (DGX) Revenue (2016 - 2026)

Quest Diagnostics' Revenue history spans 18 years, with the latest figure at $2.9 billion for Q1 2026.

  • On a quarterly basis, Revenue rose 9.16% to $2.9 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $11.3 billion, a 11.03% increase, with the full-year FY2025 number at $11.0 billion, up 11.78% from a year prior.
  • Revenue hit $2.9 billion in Q1 2026 for Quest Diagnostics, up from $2.8 billion in the prior quarter.
  • Over the last five years, Revenue for DGX hit a ceiling of $2.9 billion in Q1 2026 and a floor of $2.3 billion in Q4 2023.
  • Historically, Revenue has averaged $2.5 billion across 5 years, with a median of $2.5 billion in 2022.
  • Biggest five-year swings in Revenue: fell 14.98% in 2022 and later grew 15.19% in 2025.
  • Tracing DGX's Revenue over 5 years: stood at $2.3 billion in 2022, then decreased by 1.93% to $2.3 billion in 2023, then rose by 14.55% to $2.6 billion in 2024, then grew by 7.06% to $2.8 billion in 2025, then grew by 3.17% to $2.9 billion in 2026.
  • Business Quant data shows Revenue for DGX at $2.9 billion in Q1 2026, $2.8 billion in Q4 2025, and $2.8 billion in Q3 2025.